Nov 3 (Reuters) - Collegium Pharmaceutical Inc COLL.O :
* COLLEGIUM REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* Q3 REVENUE $127.0 MILLION
* UPDATED FULL YEAR 2022 GUIDANCE
* SEES 2022 TOTAL PRODUCT REVENUE IN THE RANGE OF $455
MILLION TO
$465 MILLION
* QTRLY GAAP EPS OF $0.01
* QTRLY ADJUSTED EARNINGS PER SHARE OF $1.10
* Q3 EARNINGS PER SHARE VIEW $-0.14, REVENUE VIEW $124.3
MILLION
-- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX555GsQ
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com;))